Comparison of Insulin Glargine with Insulin Degludec in Type 1 Diabetes Patients

被引：0
|
作者：
Kuroda, Akio
Tsuruo, Miho
Takeshi, Kondo
Aki, Nanako
Oguro, Yukari
Endo, Itsuro
Aihara, Ken-ichi
Tamaki, Motoyuki
Matsumoto, Toshio
Matsuhisa, Munehide
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
906-P
引用
收藏
页码：A232 / A232
页数：1
相关论文
共 50 条
  • [31] Local tolerability of insulin degludec is comparable to insulin glargine: a meta-analysis of trials in type 1 and type 2 diabetes
    Meneghini, L. F.
    Schumm-Draeger, P. -M.
    Harris, S.
    Gall, M. -A.
    Lassota, N.
    Christiansen, J. S.
    DIABETOLOGIA, 2012, 55 : S380 - S380
  • [32] Insulin Degludec, a New Generation Ultra-Long Acting Insulin, in a Mealtime plus Basal Regimen in People with Type 1 Diabetes:Comparison to Insulin Glargine
    Meneghini, Luigi F.
    Home, Philip D.
    Wendisch, Ulrich
    Ratner, Robert E.
    Endahl, Lars A.
    Johansen, Thue
    Lyby, Karsten
    Jendle, Johan H.
    Roberts, Anthony P.
    Devries, J. Hans
    Birkeland, Kare I.
    DIABETES, 2010, 59 : A152 - A152
  • [33] Reduced risk of hypoglycaemia with insulin degludec vs insulin glargine in patients with Type 2 diabetes requiring high dose basal insulin
    Gough, S.
    Rodbard, H.
    Handelsman, Y.
    Dykiel, P.
    Lassota, N.
    Lane, W.
    DIABETIC MEDICINE, 2013, 30 : 55 - 55
  • [34] Insulin Analogues Insulin Glargine and Insulin Glulisine in Type 1 Diabetes
    Schreiber, S. A.
    Fiesselmann, A.
    Bornstein, S. R.
    Landgraf, W.
    DIABETES STOFFWECHSEL UND HERZ, 2011, 20 (02): : 69 - 77
  • [35] In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
    Schiavon, Michele
    Visentin, Roberto
    Giegerich, Clemens
    Sieber, Jochen
    Dalla Man, Chiara
    Cobelli, Claudio
    Klabunde, Thomas
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (08) : 553 - 561
  • [36] Efficacy of insulin degludec in young persons with Type 1 diabetes after switching from insulin glargine or insulin detemir HL Tan and
    Tan, H. L.
    Chau, F.
    DIABETIC MEDICINE, 2016, 33 : 107 - 107
  • [37] A Randomized Crossover Study of the Efficacy and Safety of Switching from Insulin Glargine to Insulin Degludec in Children with Type 1 Diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Kuwabara, Remi
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    DIABETES, 2015, 64 : A366 - A366
  • [38] Effectiveness of insulin degludec in Type 1 diabetes
    Dar, S.
    Brewer, D.
    Karamat, M. A.
    DIABETIC MEDICINE, 2015, 32 : 108 - 109
  • [39] A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec in children with type 1 diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    ENDOCRINE JOURNAL, 2017, 64 (02) : 133 - 140
  • [40] Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia
    Nebojša Lalić
    Monika Russel-Szymczyk
    Marina Culic
    Christian Klyver Tikkanen
    Barrie Chubb
    Diabetes Therapy, 2018, 9 : 1201 - 1216
12345